GD2-CAR IL-15 NKT cells could improve cell persistence in vitro, augment cell localization in tumor sites, and enhance tumor control compared to GD2-CAR NKT cells in mice bearing neuroblastoma. This evidence concerns the gene IL15 and neoplasm.